Ozempic is not a healthy or long-term solution for weight loss. people need to modify their lifestyle but are too lazy or debilitated.
But RFK calling out ‘big pharma’ is a joke. He’s on pharmacological testosterone replacement as a shortcut for weight loss and gains.
Ozempic and others are certainly better than being morbidly obese. Lifestyle modification is prescribed over and over and many people struggle to adhere. Condemning them to death seems wrong.
Agree with big pharma BS. RFK is doped to the gills with the best Big Pharma has to offer
I'll also note that my original post reads somewhat garbled. I tried to use the forum's hyperlink function to change the links to explanatory text, but for whatever reason it deleted my text and posted the links at the bottom.
At the end of the day, we have almost five years of trial data showing modest to major improvements in significant metrics (mortality, coronary artery disease, heart failure). How much data should a pharmaceutical product have before it can be consumed by the public?
First, all of the data collected by the company selling the drug should be thrown out.
Then the people buying the drug should shoulder all of the risk and cost for consuming the drug. As it stands, I shoulder the cost for other people consuming the drug, for better or worse. Perverse incentives make for perverse outcomes. If they aren't expressed as cardiac arrest statistics they'll be expressed in other ways.
Finally, you don't know the meaning of the word "we." We implies you and others for whom you have been given permission to speak, not drug manufacturers and the folks who they pay to run their studies. Stop speaking for people other than yourself when you have no permission to do so.
You are asking the government to fund clinical trials for ALL investigative new drugs to the tune of tens of billions a year (probably >100 billion).
Where does that money come from?
How does the FDA decide which drugs get funded for a trial if they can’t look at data from the companies that develop them?